Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Teradata Corp
TDC
(Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -13.92%8.27M | -74.51%8.36M | 119.39%4.58M | -86.17%12.7M | -177.00%-6.07M | -21.05%9.6M | 1.25%32.8M | -160.00%-23.63M | 0.10%91.83M | -46.19%7.88M |
Net income from continuing operations | -114.05%-4.87M | -49.45%12.54M | 212.57%31.03M | -105.79%-3.95M | -508.85%-35.84M | 53.31%34.66M | -7.40%24.8M | -373.74%-27.56M | 379.97%68.22M | 1,310.91%8.77M |
Operating gains losses | 160.15%15.72M | 81.27%-3.69M | -446.79%-31.93M | 60.74%-5.51M | 895.21%46.17M | -194.45%-26.14M | -8.93%-19.7M | -170.40%-5.84M | -166.90%-14.03M | -57.33%4.64M |
Depreciation and amortization | -35.23%3.27M | -8.81%4.94M | -14.12%5.18M | -29.87%21.58M | -23.99%5.08M | -30.63%5.05M | -32.42%5.41M | -31.38%6.04M | -24.96%30.77M | -26.05%6.68M |
Deferred tax | -109.21%-547K | -83.10%1.65M | 177.95%3.95M | 112.34%4.05M | -349.76%-6.57M | 148.26%5.94M | 575.33%9.75M | -982.26%-5.07M | 127.49%1.91M | 79.02%-1.46M |
Other non cash items | -25.09%206K | 81.40%468K | 11.20%288K | -17.60%997K | -15.98%205K | -42.23%275K | 7.50%258K | 3.60%259K | 245.96%1.21M | 119.95%244K |
Change In working capital | 34.77%-7.25M | -189.75%-9.92M | -163.85%-5.31M | -143.07%-8.35M | -45.23%-16.61M | 13.95%-11.11M | -8.99%11.05M | -5.17%8.32M | -181.02%-3.44M | -424.87%-11.44M |
-Change in receivables | 1.30%-1.44M | -40.15%6.42M | -98.11%278K | -87.23%4.46M | -175.07%-19.51M | -150.03%-1.46M | 16.96%10.72M | -50.85%14.72M | 44.23%34.94M | 58.08%-7.09M |
-Change in inventory | -99.10%-2.88M | -136.58%-2.28M | 37.29%1.87M | -133.33%-486K | 87.33%562K | -75.94%-1.45M | -36.11%-965K | -49.26%1.37M | 57.79%1.46M | -52.08%300K |
-Change in prepaid assets | 85.98%-700K | -62.39%3.51M | 72.34%-833K | 130.85%654K | 91.93%-677K | -7.77%-4.99M | -59.17%9.34M | 74.83%-3.01M | -122.92%-2.12M | -21,607.69%-8.39M |
-Change in payables and accrued expense | 90.13%-395K | -77.37%-15.06M | 9.59%-4.37M | 71.86%-10.55M | 114.00%6.79M | 59.83%-4M | 56.93%-8.49M | 55.89%-4.84M | -272.02%-37.48M | -83.95%3.17M |
-Change in other current assets | -151.72%-30K | -456.23%-944K | -10.32%252K | -156.60%-163K | -226.99%-767K | 107.48%58K | 55.88%265K | -2.77%281K | 423.64%288K | 34.52%604K |
-Change in other current liabilities | -110.47%-110K | -137.79%-161K | -7,000.00%-1.31M | -186.39%-857K | -737.37%-2.35M | 83.74%1.05M | -25.65%426K | -85.16%19K | 168.27%992K | 73.34%-281K |
-Change in other working capital | -444.98%-1.68M | -473.66%-1.39M | -461.50%-1.2M | 6.48%-1.42M | -360.00%-650K | -49.28%-309K | -15.17%-243K | 84.16%-213K | 91.90%-1.51M | 104.92%250K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -13.92%8.27M | -74.51%8.36M | 119.39%4.58M | -86.17%12.7M | -177.00%-6.07M | -21.05%9.6M | 1.25%32.8M | -160.00%-23.63M | 0.10%91.83M | -46.19%7.88M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 52.78%-1.24M | -187.66%-1.56M | -591.92%-3.6M | -202.23%-6.51M | -201.71%-2.82M | -310.31%-2.63M | -1,162.79%-543K | 2.99%-520K | -254.08%-2.15M | -111.85%-935K |
Net PPE purchase and sale | 26.47%-814K | -69.61%-921K | 60.58%-205K | -25.95%-2.71M | 41.93%-543K | -72.97%-1.11M | -1,162.79%-543K | 2.99%-520K | -92.32%-2.15M | -72.19%-935K |
Net intangibles purchase and sale | 71.96%-426K | ---641K | ---3.39M | ---3.8M | ---2.28M | ---1.52M | --0 | --0 | --0 | --0 |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 52.78%-1.24M | -187.66%-1.56M | -591.92%-3.6M | -202.23%-6.51M | -201.71%-2.82M | -310.31%-2.63M | -1,162.79%-543K | 2.99%-520K | -254.08%-2.15M | -111.85%-935K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 23.88%-10.2M | -63.51%-15.06M | -166.33%-22.53M | 96.62%-2.56M | -30.67%-13.91M | 15.03%-13.4M | -12.32%-9.21M | 182.73%33.96M | 11.09%-75.66M | -25.93%-10.64M |
Net issuance payments of debt | 60.00%-2M | ---6M | -131.11%-14M | 252.17%35M | ---5M | ---5M | --0 | 260.71%45M | -24.08%-23M | --0 |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---395K | --0 |
Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -207.13%-2.28M | --0 |
Cash dividends paid | 4.19%-4.57M | -4.28%-4.83M | -4.06%-4.79M | -1.82%-18.79M | -4.00%-4.79M | -3.71%-4.77M | 0.09%-4.63M | 0.32%-4.6M | 0.18%-18.46M | 0.58%-4.6M |
Net other financing activities | 0.00%-3.63M | 7.64%-4.23M | 41.98%-3.74M | 40.48%-18.77M | 31.78%-4.12M | 65.95%-3.63M | 39.98%-4.58M | 10.71%-6.44M | 33.39%-31.53M | 9.65%-6.04M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 23.88%-10.2M | -63.51%-15.06M | -166.33%-22.53M | 96.62%-2.56M | -30.67%-13.91M | 15.03%-13.4M | -12.32%-9.21M | 182.73%33.96M | 11.09%-75.66M | -25.93%-10.64M |
Net cash flow | ||||||||||
Beginning cash position | -56.45%45.52M | -34.00%53.78M | 5.07%75.32M | 24.30%71.68M | 30.17%98.12M | 31.29%104.54M | 46.91%81.49M | 24.30%71.68M | 16.18%57.67M | 72.96%75.38M |
Current changes in cash | 50.60%-3.17M | -135.82%-8.26M | -319.64%-21.54M | -74.06%3.64M | -516.86%-22.8M | -51.30%-6.42M | -4.57%23.05M | 546.38%9.81M | 74.55%14.02M | -126.24%-3.7M |
End cash Position | -56.84%42.35M | -56.45%45.52M | -34.00%53.78M | 5.07%75.32M | 5.07%75.32M | 30.17%98.12M | 31.29%104.54M | 46.91%81.49M | 24.30%71.68M | 24.30%71.68M |
Free cash flow | 0.70%7.03M | -78.92%6.8M | 104.08%985K | -93.10%6.19M | -227.96%-8.89M | -39.45%6.98M | -0.29%32.26M | -162.16%-24.15M | 5.87%89.68M | -50.75%6.95M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |